# PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C

> **NCT00100659** · PHASE3 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 114 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Pegylated Interferon/ribavirin

## Key facts

- **NCT ID:** NCT00100659
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2008-08
- **Final completion:** 2010-02
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2018-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00100659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00100659, "PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00100659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*